With both compounds reducing energy intake (tirzepatide through appetite) and mobilizing stored energy (AOD 9604 through lipolysis), the body is working harder to maintain homeostasis
Guideline on Manufacture of the Finished Dosage Form
Experimental interest in 5-Amino-1MQ includes evaluation of its role in metabolic signaling, mitochondrial function, inflammatory marker regulation, and cellular energy utilization
For body composition studies comparing direct lipolytic agents, AOD-9604 provides a control that separates fat mobilization from muscle anabolism or glucose handling
Upon stimulation, patatin-like phospholipase domain containing 2 (PNPLA2)/adipocyte triglyceride lipase (ATGL), the rate limiting enzyme for TAG hydrolysis, is activated by the interaction with its co-activator, alpha/beta hydrolase domain-containing protein 5 (ABHD5), which is normally bound to perilipin 1 (PLIN1)
This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic